Tear lipocalin: Structure, function and molecular mechanisms of action

Advances in Experimental Medicine and Biology

Volumn 506 A, Issue , 2002, Pages 555-565

  Glasgow, Ben J ^a   Abduragimov, Adil R ^a   Gasymov, Oktay K ^a   Yusifov, Taleh N ^a  

^a JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISULFIDE; LIGAND; LIPID; LIPOCALIN; TRYPTOPHAN; WATER;

ACIDITY; BINDING AFFINITY; BINDING SITE; CONFERENCE PAPER; CONFORMATIONAL TRANSITION; CORNEA; HYDROPHOBICITY; LACRIMAL FLUID; LIGAND BINDING; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; PHASE TRANSITION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; SOLUBILITY;

EID: 0036932705     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0717-8_78     Document Type: Conference Paper

References (51)

1. R.J. Fullard. Identification of proteins in small tear volumes with and without size exclusion HPLC fractionation. Curr. Eye Res. 7:163-179 (1988).
2. A.M. Gachon, and R.J. Dastugue. Human tears, normal protein pattern and individual protein determination in adults. Curr. Eye Res. 2:301-308 (1983)
3. A. Delaire, H. Lassagne, and A.M. Gachon. New members of the lipocalin family in human tear fluid. Exp. Eye Res. 55: 645-647 (1992).
4. R.J. Fullard, D.M.Kissner. Purification of the isoforms of tear specific prealbumin. Curr. Eye Res. 10:613-628 (1991).
5. K. Inada. Studies of human tear proteins. 3. Distribution of specific tear prealbumin in lacrimal glands and other adnexa. Jpn. J. Ophthalmol. 28:315-330 (1984).
6. B.J. Glasgow. Tissue expression of lipocalins in human lacrimal and von Ebner's glands: colocalization with lysozyme. Graefe's Arch. Clin. Exp. Ophthalmol. 233:513-522 (1995).
7. B. Redl, P. Holzfeind, and F. Lottspeich. cDNA cloning and sequencing reveals human tear prealbumin to be a member of the lipophilic-ligand carrier protein superfamily J. Biol. Chem. 267:20282-202877 (1992).
8. P. Holzfeind, P. Merschak, H. Rogatsch, Z. Culig, H. Feichtinger, H. Klocker, and B. Redl. Expression of the gene for tear lipocalin/von Ebner's gland protein in human prostate. FEBS Lett. 395:95-98 (1997).
9. B. Redl, P. Wojnar, H. Ellemunter, and H. Feichtinger. Indentification of a lipocalin in mucosal glands of the human tracheobronchial tree and its enhanced secretion in cystic fibrosis. Lab. Invest. 78:1121-1129 (1998).
10. F. Scalfari, M. Casragna, B. Fattori, I. Andreini, C. Maremmmani, and P. Pelosi. Expression of a lipocalin in human nasal mucosa. Comp. Biochem. Physiol. 118B:819-824 (1998).
11. B. Fattori, M. Castagna, G. Megna, A. Casani, and P. Pelsosi. Immunohistochemical localization of tear lipocalin in human nasal mucosa. Rhinology 36:101-103 (1998).
12. E. Lacazette, A.M. Gachon, and G. Pitiot. A novel human odorant-binding protein gene family resulting from genomic duplicons at 9q34: differential expression in the orial and genital spheres. Hum. Mol. Genet. 9:289-301 (2000).
13. M. Bläker, K. Kock, C. Ahlers, F. Buck, and H. Schmale. Molecular cloning of human von Ebner's gland protein: a member of the lipocalin superfamily highly expressed in lingual salivary gland. Biochim. Biophys. Acta 1172:131-137 (1993).
14. H. Lassagne, and A.M. Gachon. Cloning of a human lacrimal lipocalin secreted in tears. Exp. Eye Res. 55:605-609 (1993).
15. D.R. Flower. The lipocalin protein family: structure and function. Biochem. J. 18:1-14 (1996).
16. B.Y. Qin, M.C. Bewley, L.K. Creamer, H.M. Baker, E.N. Baker and G.B. Jameson. Structural basis of the Tanford transition of bovine beta-lactoglobulin. Biochemistry 37:14014-14023 (1998).
17. M.Z. Papiz, L. Sawyer, E.E. Eliopoulos, A.C. North, J.B. Findlay, R .Sivaprasadarao, T.A. Jones, M.E. Newcomer, and P.J. Kraulis. The structure of beta-lactoglobulin and its similarity to plasma retinol-binding protein. Nature 324:383-385 (1986).
18. B.Y. Qin, L.K. Creamer, E.N. Baker, and G.B. Jameson. 12-Bromododecanoic acid binds inside the calyx of bovine beta-lactoglobulin. FEBS Lett. 438:272-278 (1998).
19. S.Y. Wu, M.D. Perez, P. Puyol, and L. Sawyer. Beta-lactoglobulin bends palmitate within its central cavity. J. Biol. Chem. 274:170-174 (1999).
20. O.K. Gasymov, A.R. Abduragimov, T.N. Yusifov, and B.J. Glasgow. Interaction of tear lipocalin with lysozyme and lactoferrin. Biochem. Biophys. Res. Commun. 265:322-325 (1999).
21. C. Creuzenet and D. Mangroo. Physico-chemical characterization of human von Ebner's gland protein expressed in Escherichia coli. Protein Expr. Purif. 14:254-260 (1998).
22. B.J. Glasgow, A.R. Abduragimov, T.N. Yusifov, O.K. Gasymov, J. Horwitz, W.L Hubbell, and K..F. Faull. A conserved disulfide motif in human tear lipocalins influences ligand binding. Biochemistry 37:2215-2225 (1998).
23. O.K. Gasymov, A.R. Abduragimov, T.N. Yusifov, and B.J. Glasgow. Binding studies in tear lipocalin: the role of the conserved tryptophan in maintaining structure, stability, and ligand affinity, Biochim. Biophys. Acta 1433:307-320 (1999).
24. Y. Katakura, M. Totsuka, A. Maetani, and S. Kaminogawa. Tryptophan-19 of beta-lactoglobulin the only residue completely conserved in the lipocalin superfamily, is not essential for binding retinol, but relevant to stabilizing bound retinol and maintaining its structure. Biochim. Biophys. Acta 1207:58-67 (1994).
25. B.J. Glasgow, A.R. Abduragimov, Z.T. Farahbakhsh, K.F. Faull and W.L. Hubbell. Tear lipocalins bind a broad array of lipid ligands. Curr. Eye Res. 14:363-372 (1995).
26. B.J. Glasgow, A.R. Abduragimov, O.K. Gasymov, T.N. Yusifov, E.C. Ruth, and K.F. Faull. Vitamin E associated with the lipocalin fraction of human tears. Third International Conference on the Lacrimal Gland, Tear Film and Dry Eye Syndromes: Basic Science and Clinical Relevance. in press.
27. B.J. Glasgow, A.R. Abduragimov, T.N. Yusifov, and O.K. Gasymov. Studies of ligand binding and CD analysis with apo- and holo- tear lipocalins. Adv. Exp. Med Biol. 483:105-112 (1998).
28. H. Schmale, H. Holgreye-Grez, and H. Christiansen. Possible role for salivary gland protein in taste reception indicated by homology to lipophilic-ligand carrier proteins. Nature 343:366-369 (1990).
29. M.E. Selsted, and R.J. Martinez. Isolation and purification of bactericides from tears. Exp. Eye Res. 34:305-318 (1982).
30. A.S. Josephson, and A. Wald. Enhancement of lysozyme activity by anodal tear protein. Proc. Soc. Exp. Biol. Med. 131:677-679 (1969).
31. T.N. Yusifov, A.R. Abduragimov, O.K. Gasymov, and B.J. Glasgow. Endonuclease activity in lipocalins. Biochem J. 347:815-919 (2000).
32. W. van't Hof, M.F. Blankenvoorde, E.C.I. Veerman, and A.V. Amnerangen. The salivary lipocalin von Ebner's gland protein is a cysteine proteinase inhibitor. J. Biol. Chem. 272:1837-1841 (1997).
33. B. Redl, P. Wojnar, H. Ellemunter, and H. Feichtinger. Identification of a lipocalin in mucosal glands of the human tracheobronchial tree and its enhanced secretion in cystic fibrosis. Lab Invest. 78:1121-1129 (1998).
34. B.J. Glasgow, G. Marshall, O.K. Gasymov, A.R. Abduragimov, T.N. Yusifov, and C.M. Knobler. Tear lipocalins: potential lipid scavengers for the corneal surface. Invest. Ophthalmol Vis. Sci. 40:3100-3107.26 (1999).
35. B. Nayová, and J.M. Tiffany. Components responsible for the surface tension in tears. Curr. Eye Res. 19:4-11 (1999).
36. P.T. Janssen, and O.P. van Bijsterveld. Tear fluid proteins in Sjögren's syndrome. Scand J. Rheumatol. 61:224-227 (1986).
37. R.D. Schoenwald, S. Vidvauns, D.E. Wurster, and C.F. Barfknecht. Tear film stability of protein extracts from dry eye patients administered a sigma agonist. J. Ocul. Pharmacol. Ther. 13:151-161 (1997).
38. Tiffany JM, Winter N, and Bliss G. Tear film stability and tear surface tension. Curr. Eye Res. 8:507-515 (1989).
39. F.J. Holly. Formation and stability of tear film. Int. Ophthalmol. Clin. 13:73-96 (1973).
40. O.K. Gasymov, A.R. Abduragimov, T.N. Yusifov, and B.J. Glasgow. Structural changes in tear lipocalins with ligand binding. Biochim. Biophys. Acta. 1386:145-156 (1998).
41. J.C. Pandit, B. Nagyová, J.A. Bron, and J.M. Tiffany, Physical properties of stimulated and unstimulated tears. Exp. Eye Res. 68:247-253 (1998).
42. F.J. Holly, and M.A. Lemp. Wettability and wetting of corneal epithelium. Exp. Eye Res. 11:239-250 (1971).
43. M. Prats, J. Teissié, and J.F. Tocanne. Lateral proton conduction at lipid-water interfaces and its implications for the chemiosmotic-coupling hypothesis. Nature 322:756-758 (1986).
44. B. Redl, P. Merschak, B. Abt, and P. Wojnar. Phage display reveals a novel interaction of human tear lipocalin and thioredoxin which is relevant for ligand binding. FEBS Lett. 460:182-186 (1999).
45. M.R. Eftink, and C.A. Ghiron. Exposure of tryptophanyl residues in proteins. Quantitative determination by fluorescence quenching studies. Biochemistry 15:672-680 (1976).
46. J.R. Lakowicz. Principles of Fluorescence Spectroscopy. Plenum Press, New York (1983).
47. E.A. Burstein, N.S. Vedenkina, and M.N. Ivkova. Fluorescence and the location of tryptophan residues in protein molecules. Photochem. Photobiol. 18:263-279 (1973).
48. O.K. Gasymov, A.R. Abduragimov, N. Yusifov, and B.J. Glasgow. Solution structure by site directed tryptophan fluorescence in tear lipocalin. Biochem. Biophys. Res. Commun. 239:191-196 (1997).
49. B.J. Glasgow, O.K. Gasymov, A.R. Abduragimov, T.N. Yusifov, C. Altenbach, and W.L. Hubbell. Side chain mobility and ligand interactions of the G strand of tear lipocalins by site-directed spin labeling. Biochemistry 38:13707-13716 (1999).
50. W.L. Hubbell, A. Gross, R. Langen, and M.A. Leitzow. Recent advances in site-directed spin labeling of proteins. Curr. Opin. Struct. Biol. 8:649-656 (1998).
51. O.K. Gasymov, A.R. Abduragimov, T.N. Yusifov, and B.J. Glasgow. Resolution of ligand positions by site directed tryptophan fluorescence in tear lipocalin. Protein Science 9:325-331 (2000).